Objective-Collagen accumulation and calcification are major determinants of atherosclerotic plaque stability. Extracellular vesicle (EV)-derived microcalcifications in the collagen-poor fibrous cap may promote plaque rupture. In this study, we hypothesize that the collagen receptor discoidin domain receptor-1 (DDR-1) regulates collagen deposition and release of calcifying EVs by vascular smooth muscle cells (SMCs) through the transforming growth factor-β (TGF-β) pathway. Approach and Results-SMCs from the carotid arteries of DDR-1 −/− mice and wild-type littermates (n=5-10 per group) were cultured in normal or calcifying media. At days 14 and 21, SMCs were harvested and EVs isolated for analysis. Compared with wild-type, DDR-1 −/− SMCs exhibited a 4-fold increase in EV release (P<0.001) with concomitantly elevated alkaline phosphatase activity (P<0.0001) as a hallmark of EV calcifying potential. The DDR-1 −/− phenotype was characterized by increased mineralization (Alizarin Red S and Osteosense, P<0.001 and P=0.002, respectively) and amorphous collagen deposition (P<0.001). We further identified a novel link between DDR-1 and the TGF-β pathway previously implicated in both fibrotic and calcific responses. An increase in TGF-β1 release by DDR-1 −/− SMCs in calcifying media (P<0.001) stimulated p38 phosphorylation (P=0.02) and suppressed activation of Smad3. Inhibition of either TGF-β receptor-I or phospho-p38 reversed the fibrocalcific DDR-1 −/− phenotype, corroborating a causal relationship between DDR-1 and TGF-β in EV-mediated vascular calcification. Conclusions-DDR-1 interacts with the TGF-β pathway to restrict calcifying EV-mediated mineralization and fibrosis by SMCs. We therefore establish a novel mechanism of cell-matrix homeostasis in atherosclerotic plaque formation. (Arterioscler Thromb Vasc Biol. 2016;36:525-533. (M.P.B.) . The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
V ascular calcification is a predictor of cardiovascular events and a major determinant of atherosclerotic plaque stability. 1 Although macrocalcifications in the collagen-dense fibrous cap may promote structural stability of the plaque, microcalcifications in collagen-poor areas exert mechanical stress on the surrounding tissue, thus potentiating the risk of rupture and subsequent cardiovascular events. 2 Several determinants that further influence plaque stability have been identified, among which a high number and close spatial proximity of microcalcific deposits as well as a thin collagenous fibrous cap constitute the conditions most favorable for stress-induced rupture. 3 Emerging evidence suggests that vascular wall cells, including smooth muscle cells (SMCs) and macrophages, release calcifying extracellular vesicles (EVs) prone to aggregation in the extracellular matrix (ECM) and formation of calcific foci in the plaque. [4] [5] [6] [7] [8] However, the regulation of collagen production and calcifying EV release by SMCs is incompletely understood.
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Discoidin domain receptors (DDRs)-1 and 2 are a family of 2 receptor tyrosine kinases that exhibit substrate specificity for both fibrillar and nonfibrillar collagens. 9 DDR activity has been implicated in physiological processes such as cell migration, 10 differentiation, 11 and ECM remodeling, 12 whereas dysregulated DDR function has been linked to the progression of fibrosis, arthritis, and cancer. 13 DDR-1, composed of 5 membrane-bound and 2 secreted isoforms generated by alternative splicing, 14 was found to play a complex role in the progression of atherosclerotic plaque formation. 15 By contrast, DDR-2 does not affect SMC migration, proliferation, or ECM remodeling in vitro. 16 Ahmad et al 17 found that DDR-1 influences in vivo vascular calcification using DDR-1/low-density lipoprotein (LDL)-receptor double-knockout mice. Recent findings on the role of DDR-1 in fibrocalcific response and the emerging influence of EVs in vascular calcification highlight a possible impact of DDR-1 on the fibrocalcific potential of SMCs and their release of calcifying EVs. Despite extensive knowledge of the numerous pathways involved in DDR-1 downstream signaling, 14 a functional link between DDR-1 signaling and its role in EV-mediated calcification as a predictor of atherosclerotic plaque stability remains to be elucidated.
Transforming growth factor-β (TGF-β) and its signaling pathways are strongly associated with SMC-mediated fibrosis 18 and calcification, 19 suggesting a potential regulatory role in SMC osteogenic differentiation and fibrocalcific response. A canonical pathway featuring the Smad proteins, Smad2 and Smad3, and several noncanonical pathways comprising the MAPkinases Erk1/2, JNK, and p38/MAPK are involved in TGF-β receptor activation. Both the pathways are known to cross-talk with each other resulting in synergistic or antagonistic effects on potentially desirable biological outcomes. 20 In the context of atherosclerotic plaque progression, TGF-β1 promotes the osteogenic differentiation 21 and calcifying potential 22 of SMCs in vitro, and it is abundantly expressed in calcified human atheromata. 23 The effect of TGF-β pathways on EV release and the fibrocalcific response in SMCs, however, remains unclear.
In this study, we hypothesize that DDR-1 signaling regulates EV-mediated SMC fibrocalcific responses via TGF-β pathways. Wu et al 24 observed that DDR-1 depletion increases chondrogenic differentiation through enhanced expression of chondrogenic markers, such as SOX-9 and collagen II, in human adipose-derived stem cells. Moreover, the knockdown of DDR-1 in a tumor cell model reportedly stimulated the expression of TGF-β1 on the RNA and protein level. 25 On the basis of these findings, we demonstrate a functional cross-talk between DDR-1 and the TGF-β pathways involving Smad3 and p38 to regulate the release of calcifying EVs by SMCs. This study introduces a novel mechanism balancing vascular fibrocalcific response in atherosclerotic plaque formation.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

DDR-1 Deficiency Increases the Release of Calcifying EVs in SMCs
Nanoparticle tracking analysis of collagenase digested, purified supernatant from SMCs after 14 and 21 days of culture showed a uniform size distribution with a mean particle size of 180 to 200±100 nm throughout all samples and time points ( Figure 1A ). These findings are consistent with previous data on EV size distribution. 26 Compared with wild-type (WT) littermates, DDR-1 −/− SMCs exhibited a significant increase in the release of EVs by 3.5-fold in normal media (P=0.0004) and 4-fold in calcifying media (P=0.003) at day 14 and a 2.5fold increase in both media at day 21 (P<0.001; Figure 1B ). Transmission electron microscopic imaging of SMCs after 21 days of culture displayed dense clusters of DDR-1 −/− SMCs surrounded by abundant ECM, whereas WT cells showed sparse cell growth and little ECM production ( Figure 1C ). Transmission electron microscopic images demonstrated an increased number of membrane-bound vesicular bodies in proximity with DDR-1 −/− compared with WT SMCs. The particles displayed via transmission electron microscopy were found to match the EV size distribution observed using nanoparticle tracking analysis ( Figure IB in the online-only Data Supplement), confirming our finding of elevated EV release by DDR-1 −/− SMCs. Further analysis of the calcifying potential of isolated EVs revealed an increase in alkaline phosphatase (ALP) activity in EVs from DDR-1 −/− compared with WT SMCs by 1 order of magnitude in both normal and calcifying media after 14 (P<0.0001) and 21 days (P<0.01, Figure 1D ). The presence of β-glycerophosphate (β-GP) in calcifying media, mimicking osteogenic conditions, further induced EV release and ALP activity in EVs from WT (46.1±23.0 versus 107.5±7.4 ng/well per mg protein, P<0.05; Figure V in the online-only Data Supplement) and DDR-1 −/− SMCs (581.3±68.3 versus 878.2±155.4 ng/well per mg protein, P<0.05) significantly, thus augmenting their calcifying potential.
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DDR-1 −/− SMCs Propagate Calcification Through the Expression of a Procalcific Phenotype
Consistent with elevated EV calcification potential, DDR-1 −/− SMCs exhibited increased ALP activity compared with WT SMCs as shown by a colorimetric staining assay after 14 and 21 days of culture ( Figure 2A ). An ALP activity assay performed on cell lysates concordantly showed a significant increase in the presence of cytoplasmic and cell membranebound ALP in DDR-1 −/− SMCs in both normal and calcifying media at days 14 (P=0.0003) and 21 (P<0.01, Figure 2B ). The addition of β-GP in calcifying media resulted in a linear increase in ALP activity during the 21 days of SMC culture similar to that observed in EVs, suggesting a direct relationship between ALP expression in SMCs and EV calcifying potential. Gene expression at 14 days of culture showed a concordant 6-and 9-fold upregulation of ALP mRNA in normal and calcifying media, respectively (P<0.01, Figure 2E ). Further analysis of osteogenic differentiation in DDR-1 −/− SMCs revealed a 56.1±38.5-fold increase in the synthetic marker osteopontin, along with a 6.6±4.3-fold increase in the osteogenic marker Msx2 (P<0.01), whereas no significant difference compared with WT was observed in related markers vimentin and Runx2 ( Figure VI in the online-only Data Supplement). Compared with WT, DDR-1 −/− SMCs exhibited increased Alizarin Red S-positive mineral deposition. Mineralization of DDR-1 −/− cultures in calcifying media visibly progressed from days 14 to 21 with a >30-fold increase in Alizarin Red S absorbance compared with WT at day 21 (P=0.0005, Figure 2C and 2D).
Calcific mineral deposition in the ECM is regulated by a balance of inorganic phosphate and pyrophosphate, which is dependent on ALP and its antagonist ectonucleotide pyrophosphatase/phosphodiesterase-1 ( Figure IA in the online-only Data Supplement). 27 ALP produces phosphate for calcium phosphate complexation, whereas ectonucleotide pyrophosphatase/phosphodiesterase-1 generates pyrophosphate, an inhibitor of mineralization. In DDR-1 −/− SMCs, the increase in ALP activity in EVs and ALP expression in SMCs was accompanied by a concomitant increase in ectonucleotide pyrophosphatase/phosphodiesterase-1 activity in EVs in calcifying media ( Figure IB 
DDR-1 Regulates EV-Induced Fibrocalcific Response in SMCs Through TGF-β1 Downstream Signaling Pathways
Members of the TGF-β family modulate vascular fibrosis and calcification. 20 In calcifying media, DDR-1 −/− SMCs release elevated levels of TGF-β1 compared with WT after 21 days of culture ( Figure 3A ). TGF-β1 gene expression is doubled relative to WT in DDR-1 −/− SMCs in both media at day 14 ( Figure 3B ). Western blot analysis of TGF-β canonical and noncanonical pathways after 21 days of culture showed a near-complete suppression of Smad3 phosphorylation (P<0.0001, Figure 3C ) and a significant decrease in phosphorylated JNK ( Figure IVB Figure 3D ). These in vitro and in vivo findings support our hypothesis on a relationship between DDR-1 and TGF-β downstream signaling with manifold implications in vascular calcification.
Inhibition of TGF-β Receptor Type I and p38 Mitigate the Osteogenic Potential of the DDR-1 −/− Phenotype
The influence of DDR-1 on p38 and Smad3 phosphorylation as well as on TGF-β1 release by SMCs raises the question whether these pathways contribute to the osteogenic phenotype exhibited by DDR-1 −/− SMCs and their release of calcifying EVs. After 21 days of culture in calcifying media, the addition of specific TGF-β receptor-I inhibitor SB431542 abrogated the previously observed 30-fold increase in calcific mineral deposition by DDR-1 −/− SMCs (P<0.0001, Figure 4A and 4B). Moreover, SB431542 treatment reduced EV release by DDR-1 −/− SMCs (P<0.0001, Figure 4C ) and mitigated EV calcification potential demonstrated by a decrease in ALP activity (P<0.01, Figure 4D ). Similarly, SB203580, a selective inhibitor of phospho-p38 MAPkinase downstream signaling, significantly suppressed EV release in DDR-1 −/− SMCs in normal (P<0.0001) and calcifying media (P<0.0001, Figure 4C ) along with a significant decrease in EV ALP activity in normal (P<0.001) and calcifying media (P<0.0001, Figure 4D ). Thus, inhibition of TGF-β signaling by either SB431542 or SB203580 has an equal impact on major calcification end points, including EV release and EV calcifying potential (P<0.0001, Figure 4A and 4B). In DDR-1 −/− SMCs, SB431542 and SB203580 consistently attenuated the activity of cytoplasmic and membrane-bound ALP (P<0.05) and ectonucleotide pyrophosphatase/phosphodiesterase-1 (P<0.01) after 14 days ( Figure IIIA and IIIB in the online-only Data Supplement).
DDR-1 Exerts a Negative Feedback on Quantitative Collagen Synthesis in Response to Extracellular Collagen
DDR-1 acts as a sensor for type I collagen in SMCs, activating a negative feedback loop on collagen synthesis in human SMCs. 12 In DDR-1 −/− SMCs, lack of collagen feedback from fibrillar collagen in the ECM not only resulted in increased collagen production (P<0.001, Figure 5B ) but also led to defined changes in the 3-dimensional structure of collagen fibers. The fluorescently labeled collagen-binding protein CNA35 28 detected a dense network of amorphous collagen fibers devoid of spatial organization in cultures of DDR-1 −/− SMCs after 21 days, whereas collagen produced by WT SMCs was found to be less dense (P<0.001), more fibrillar, and restricted to the immediate vicinity of the SMCs (Figure 5A ). The addition of β-GP in calcifying media increased calcification in DDR −/− SMCs compared with WT as detected by a fluorescent calcium tracer 29 (P=0.002). Addition of SB431542 reduced collagen synthesis (P<0.01) and calcific deposition in calcifying media (P<0.01) in DDR-1 −/− SMCs. Thus, TGF-β receptor inhibition re-established WT conditions in DDR-1 −/− SMCs ( Figure 5A and 5B ).
DDR-1 Deficiency Triggers TGF-β-Mediated Calcific EV Release and Fibrotic Response In Vivo
On the basis of these findings demonstrating a fibrocalcific phenotype of DDR-1 −/− SMCs through an interaction with TGFβ signaling in vitro, we investigated the interactions between SMCs, DDR-1, TGF-β1, and atherosclerotic plaque formation in vivo. The aortic arches of LDL-receptor knockout (LDL-R −/− ) and DDR-1 −/− LDL-R −/− mice on a 24-week highfat diet were analyzed for the presence and distribution of calcific EVs, collagen, and TGF-β1 expression.
Picrosirius Red staining revealed the spatial arrangement and packing density of collagen fibers under polarized light by enhancing natural birefringence. Although green colors indicate thin, poorly packed collagen, increased thickness, and packing density causes a shift in birefringence to the reddishorange spectrum. 30 DDR-1 −/− LDL-R −/− aortic arches exhibited a network of thick, densely packed collagen fibers that were nearly undetectable in LDL-R −/− tissue sections ( Figure 5C ). For quantitative analysis, Picrosirius Red-stained collagen was categorized into thin and loose (green), medium-sized (yellow) and thick, and densely packed fibers (orange-red). Mature, medium-sized fibers were expressed constitutively in the vessel wall of both groups regardless of fibrotic response (P=0.89, not shown), and they were therefore excluded from analysis. Quantification of thin fibers (green) relative to thick bundles (red-orange) revealed a shift toward thick, densely packed collagen (45.53±19.78% versus 54.47±19.78% thin fibers, P=0.01) in DDR-1 −/− LDL-R −/− , whereas in LDL-R −/− , thin fibers were found to be more abundant (81.90 versus 18.10±9.60% thick fibers, Figure 5D ).
Consistent with in vitro findings, immunohistochemistry for TGF-β1 detected positive areas in sections from DDR-1 −/− LDL-R −/− mice in proximity to areas positive for thick, densely packed collagen. In LDL-R −/− aortic sections, however, TGF-β1 staining was scarce and rarely found in the vascular interstitium ( Figure 5C Analysis of calcific EVs and EV aggregates using density-dependent color scanning electron microscopy, a novel method identifying early stages of calcification in the form of calcifying vesicular structures, 7 showed a multitude of isolated and aggregating vesicular particles of equal density as adjacent calcific deposits in plaque areas from DDR-1 −/− LDL-R −/− mice, bearing strong morphological resemblance to calcifications found in human atheromata ( Figure 5E ). By contrast, plaques from LDL-R −/− mice presented as mostly fibrotic with only few vesicular structures and calcific deposits of nodular appearance, revealing a pattern of calcific EV release consistent with nanoparticle tracking analysis and transmission electron microscopic analyses.
Discussion
These findings provide a novel perspective on EV-mediated vascular fibrocalcific response, a crucial determinant of atherosclerotic plaque stability. DDR-1 −/− SMCs exhibited a predominantly osteogenic and synthetic phenotype, concomitant with an increase in all measured end points of SMC-mediated fibrocalcific response both in vitro and in vivo. These included calcifying EV release [4] [5] [6] and ALP activity 29 as facilitators of mineralization and collagen synthesis as a hallmark of fibrosis, along with enhanced expression of synthetic and osteogenic markers. Microcalcifications in collagen-poor areas of the plaque have proven detrimental to its structural stability, exerting mechanical stress on surrounding tissue, and increasing the risk of rupture. 2, 3 We recently demonstrated that collagen acts as a scaffold for EV accumulation and formation of macro-or microcalcifications 8 ; however, the cellular mechanisms regulating the release of calcifying EVs in response to collagen are unknown. This study introduces DDR-1 as a novel molecular regulator controlling fibrocalcific remodeling of the ECM in atherosclerotic plaques through a previously unknown interaction with TGF-β pathways, thus associating TGF-β1 with EV release in SMCs. DDR-1 was found to restrict TGF-β1 release and subsequent p38 phosphorylation in SMCs, thereby limiting EV-mediated calcification and collagen matrix production. Furthermore, this study complements previous work on a DDR-1-activated negative feedback loop on collagen synthesis and remodeling. 12, 15 DDR-1 acts as a sensor for ECM collagen and, in response, limits collagen synthesis and calcific EV release by SMCs, promoting ECM homeostasis. Our findings of enhanced fibrocalcification in vitro, increased fibrotic remodeling, ALP expression and an abundance of calcific EVs in the DDR-1 −/− model in vivo support this conclusion.
An explanation for the differences between this study and the study by Ahmad et al 17 on SMC-mediated calcification is given by the use of different calcifying conditions. Although Ahmad et al 17 induced calcification in vitro using a highphosphate medium prone to spontaneous, ALP-independent mineral formation, 31 this study used media supplemented with β-GP, a specific ALP substrate with low tendency for cellindependent Ca 2+ complexation. 32 The differences between currently established in vitro calcification models may reflect different pathologies, 33 the high-phosphate media mimicking the pathogenesis of medial calcification in chronic kidney disease, 34 whereas β-GP may promote osteogenic changes by stimulating ALP activity, 35 The effects of TGF-β1 on atherosclerotic plaque formation are pleiotropic and presumably pathway dependent. 36 Our study introduces a novel link between DDR-1 and the TGF-β pathway in conjunction with the release of calcifying EVs, establishing a potent regulatory circuit involving DDR-1 activation, calcified plaque formation, and subsequent destabilization. Our findings indicate that DDR-1 cross-talk with TGF-β1 signaling is independent of bone morphogenetic protein and osteogenic regulator Runx2, 37 whereas influencing the expression of Msx2, a Runx2-independent promoter of cytokine-mediated osteogenic vascular calcification interacting with the Wnt pathway 38 (Figure VI associated with the fibrocalcific DDR-1 −/− phenotype in vitro and in vivo. These findings complement previous work on the positive effect of phospho-p38 on ALP expression and activity. 39 The reversal of enhanced mineral deposition, calcific EV release, and ALP activity in DDR-1 −/− SMCs by SB203580 further suggests a causal relationship between p38 phosphorylation and EV-induced fibrocalcific response. We hereby add new evidence to the controversial claims in current literature, either confirming 14, 40 or refuting 41 an interaction between DDR-1 and p38 signaling. The near-complete suppression of phospho-Smad3 concomitant with enhanced mineralization observed in DDR-1 −/− models both in vitro and in vivo supports the findings obtained by Shimokado et al 42 using Smad3 −/− SMCs. TGF-β1 itself is identified as an atherogenic agent, its expression and release related to advanced fibrosis and calcific deposition in human atheromata. 24, 43 Moreover, the observed increase in expression and release of TGF-β1 by the DDR-1 −/− model in vitro and in vivo concurs with a previous study on DDR-1 knockdown in a human cancer cell model. 25 Interestingly, the suppression of p38 phosphorylation and TGF-β1 release in DDR-1 −/− SMCs by SB431542 suggests a link between TGF-β receptor activation and the p38 pathway that has been implicated in aortic valve calcification. 44 In our DDR-1 −/− LDL-R −/− mouse model, we observed a strong association of TGF-β1-positive areas with Picrosirius Red-positive fibrotic regions and abundantly present calcific EVs forming compact calcifications similar to those found in human atheromata. This evidence purports a role of TGF-β pathways crucial to the fibrocalcific DDR-1 −/− phenotype both in vitro and in vivo.
Collectively, we conclude that DDR-1 provides a novel connection between vascular SMC-induced fibrosis and EV-mediated calcification in early-stage atherosclerotic plaque formation through the adverse regulation of 2 TGF-β signaling pathways. By restricting TGF-β1 release in SMCs, DDR-1 suppresses phosphorylation of proatherogenic p38 and increases phospho-Smad3, resulting in attenuated fibrosis and calcifying EV release ( Figure 6 ). Although further studies are required to elucidate the detailed mechanisms of DDR-1 signaling, the novel role of DDR-1 in maintaining fibrocalcific homeostasis in SMCs using the TGF-β pathway provides a new perspective on the pathogenesis of plaque formation. DDR-1 hereby exerts a TGF-β1-mediated negative feedback on both fibrotic and calcific responses, preventing earlyonset ECM remodeling in the process of plaque formation. The interaction between DDR-1, the TGF-β pathway, and the release of calcifying EVs further provides a range of potential implications in congenital and acquired disorders associated with pathological vascular calcification. Our findings introduce a heretofore-undisclosed mechanism regulating vascular fibrocalcific response and ECM remodeling as major determinants of atherosclerotic plaque stability.
